Name: 亚太炭疽处理市场规模、份额和趋势分析报告——2033年工业概况和预测
Creator: Data Bridge Market Research
License: https://www.databridgemarketresearch.com/privacy-policy

Asia Pacific Anthrax Treatment Market

市场规模（十亿美元）

CAGR : 5.43 %

USD 82.50 Billion USD 125.94 Billion 2025 2033

Forecast Period	2026 –2033
Market Size (Base Year)	USD 82.50 Billion
Market Size (Forecast Year)	USD 125.94 Billion
CAGR	5.43 %
Major Markets Players	Pfize Inc.(美国) Bayer AG(德国) GlaxoSmithKline plc(英国) Sanofi(法国) Merck & Co.(美国)

亚太炭疽治疗市场分治,按类型(阴性炭疽、肺上炭疽和肠道炭疽)、管理路线(Oral、Patheral等)、最终用户(政府组织、医院、学术和研究所等)----2033年行业趋势和预测

亚太炭疽治疗市场概况

亚太炭疽治疗市场价值2025年82.5亿美元预计将达到截至2033年1259.4亿美元,生长在一个2026年至2033年CAGR为5.43%亚太炭疽治疗市场正在稳步增长,其动力是动物疫病意识的提高、牲畜依赖地区炭疽发作的发生率上升以及政府传染病监测和防备举措的扩大。新兴经济体对公共卫生基础设施和生物防御方案的投资不断增加,进一步支持了市场扩张。

农业工人、兽医和农村畜牧农牧区居民中炭疽感染的风险正在增加,同时加强疾病控制和疫苗接种方案的监管框架,这促使人们需要有效的治疗方法,包括抗生素、免疫球蛋白和辅助护理疗法。此外,诊断能力的提高和更快速的爆发反应机制正在鼓励早期发现和及时治疗,从而降低死亡率并在整个亚太区域支持持续采用炭疽治疗。

主要市场趋势和见解

中国主导了亚太炭疽治疗市场,2025年收入份额最大,为35.12%,辅以强大的公共卫生基础设施、大规模政府储备方案以及先进的传染病监测系统。
皮下炭疽部分在2025年占了58.42%的市场份额,原因是其流行率高于其他炭疽形式,而且诊断和治疗管理相对容易。
印度是该地区增长最快的国家,预计在2026年至2033年期间,通过扩大医疗保健、增加生物防御准备投资以及改善医院和诊断基础设施,印度的CAGR将达到7.8%。
由于越来越重视早期发现、关键护理准备和生物防御威胁的防范,预计肺炭疽是预测期间增长最快的分型。
2025年,父母管理途径主导了市场,其支持是其快速治疗行动和在医院紧急治疗协议中广泛使用严重炭疽感染。
医院是2025年最大的最终用户部分,其动力是提供特别护理设施和炭疽管理标准化治疗准则。

市场大小和预测

亚太市场价值(2025):82.5亿美元
预期市场价值(2033): 125.94美元 10亿
CAGR预测(2026-2033):5.43%
2025年主要地区:中国.
最快增长地区:印度

范围和亚太炭疽治疗市场分化

属性	炭疽治疗密钥市场透视
覆盖部分	按类型 :皮下炭疽、肺上炭疽和肠内炭疽按行政路线分列:口述、家长及其他按终端用户 :政府组织、医院、学术研究所等
涵盖国家	亚太中国 * 日本 • 印度韩国新加坡马来西亚澳大利亚泰国印度尼西亚菲律宾亚太其他地区
关键市场玩家	• 辉瑞公司(美国) • Bayer AG(德国) • GlaxoSmithKline plc(英国) • 萨诺菲(法国) • 默克公司(美国) • Johnson & Johnson(美国) • AstraZeneca plc(英国) • Novartis AG(瑞士) • F. Hoffmann-La Roche有限公司(瑞士) • 西普拉有限公司(印度) • 太阳制药工业有限公司(印度) * Reddy博士实验室有限公司(印度) • 鲁平有限公司(印度) • Mylan N.V.(Viatris Inc.)(美国) • 泰瓦制药工业有限公司(以色列) • Eli Lily和Company(美国) • 武田制药有限公司(日本) • CSL有限公司(澳大利亚) • Biogen Inc.(美国) • 印度血清研究所 • Bharat生物技术国际有限公司(印度) • Aurobindo Pharma有限公司(印度) • Hetero实验室有限公司(印度) • Intas制药有限公司(印度) • Zydus生命科学有限公司(印度) • 阿伦比克制药有限公司(印度) • 尼古拉斯·皮拉马尔印度有限公司(印度) • 沃克哈特有限公司(印度) • 上海制药控股有限公司(中国) • 锡诺法尔集团有限公司(中国) • Takara Bio公司(日本) • 三菱田北制药公司(日本) • Otsuka制药有限公司(日本) • 卡肯制药有限公司(日本) • 桑多兹国际股份有限公司(瑞士) • 辉瑞澳大利亚私人有限公司(澳大利亚) • 韩国制药有限公司(韩国) • 韩美制药有限公司(韩国) • Celltrion公司(韩国)
市场机会	增加政府对传染病监测和生物防御方案的投资牲畜依赖区对有效炭疽治疗的需求增加诊断技术和定向治疗方法的进步
添加数据信息集的值	除了对市场价值,增长率,分化,地域覆盖,主要角色等市场情景的深刻认识外,由"数据桥市场研究"负责的市场报告还包括深入的专家分析,地域代表性的公司生产和能力,经销商和合作伙伴的网络布局,详细更新的价格趋势分析和供应链和需求赤字分析等.

亚太炭疽治疗市场趋势

趋势:日益重视炭疽准备和先进治疗战略

政府、保健组织和研究机构正日益加强炭疽反应准备方案,因为其潜在影响是:炭疽杆菌公共卫生、牲畜管理和生物防御方面的感染。越来越强调快速诊断、有效抗生素的提供以及炭疽抗毒素疗法的发展,正在影响治疗市场的增长。先进的卫生保健系统正在采用经改进的诊断工作流程和治疗规程来降低与吸入炭疽等严重形式有关的死亡率。此外,增加对生物防御研究、疫苗研制和应急基础设施的投资正在支持全球对炭疽治疗办法的需求。

亚太炭疽治疗市场动态

主要市场驱动力:增加政府在生物防御和传染病防备方面的投资

政府日益重视防范生物威胁,是全球炭疽治疗市场的一个主要驱动力。各国正在扩大抗生素、疫苗和炭疽抗毒素的战略储存,以确保在可能爆发或生物恐怖主义事件中作出快速反应。美国卫生与公众服务部等组织以及国家公共卫生机构都支持针对生物威胁的医疗对策的采购举措.

例如,在2023年3月 (中文(简体) ).制药公司和其他生物技术公司继续推进传染病和生物疗法研究,反映出业界对制定有针对性的治疗方法的更广泛兴趣。同样地,美国国家战略储存维持了包括抗生素和疫苗在内的重要医疗对策,以支持应对生物威胁的应急准备. 增加政府用于公共卫生安全的资金,特别是在全球传染病挑战之后,正在鼓励继续投资于炭疽治疗的开发和供应准备。

主要限制/挑战:有限的疾病发病率和高度发展的复杂性

全球炭疽治疗市场面临的一个主要挑战是,与其他传染病相比,自然出现的人类炭疽病例相对较少,这会限制对广泛开发药物的商业刺激。炭疽处理产品往往需要专门的研究、监管审批途径和注重生物防御的投资,从而增加发展的复杂性和成本。

此外,通过储存保持备战状态也给产品储存寿命、更换周期和库存管理带来挑战。制药公司必须兼顾持续提供炭疽对策的需要与不确定的需求模式,使市场扩张在很大程度上依赖于政府采购方案,而不是常规的临床需求.

主要市场机会:发展高级抗毒素、疫苗和有针对性的疗法

下一代炭疽疗法的开发为市场参与者提供了巨大的增长机会。单克隆抗体技术、重组疫苗和有针对性的抗微生物方法方面的进步正在提高治疗效果,特别是在涉及由毒素引起的并发症的严重感染方面。

例如,在2020年12月 (中文(简体) ).因此,Elusys治疗炭疽性炭疽抗毒素(obiltoxaximab)继续被认为是吸入炭疽治疗的重要医学对策,支持了抗毒素疗法与抗生素的作用. 此外,各国政府、生物技术公司和研究组织之间日益加强的合作正在加速生物防御治疗方面的创新。新兴市场,包括亚太和中东各国,正在投资于保健基础设施和应急准备方案,为炭疽治疗制造商创造更多机会。

亚太炭疽治疗市场范围

亚太炭疽治疗市场按类型、管理路线和终端用户划分。

按类型

根据类型,亚太炭疽治疗市场被分解为皮下炭疽,肺上炭疽和肠道炭疽. 皮下炭疽部分在2025年占了58.42%的市场份额,原因是其流行率高于其他炭疽形式,而且诊断和治疗管理相对容易。在报告的感染中,阴道炭疽占大多数,特别是在牲畜接触严重、从事农业活动以及农民、兽医和动物饲养者面临职业风险的地区。这一部分得益于广泛提供抗生素疗法,包括口服和注射式治疗方案,以及提高对早期诊断和感染管理的认识。政府疾病监测方案以及整个亚太国家获得医疗保健的机会的改善进一步支持了部分增长。

肺上炭疽部分预计将在2026至2033年达到6.8%的CAGR增长最快,其动力是日益重视先进的诊断能力、生物防御准备和严重炭疽感染的快速治疗方法。肺上炭疽因其高死亡率风险和与生物威胁的潜在联系而被认为是最严重的形式之一,从而产生了对专门治疗解决方案的需求. 预计增加对传染病防备、紧急保健基础设施和研究活动的投资将加快采用这一部门的先进治疗办法。

按行政路线分列

根据管理路线,亚太炭疽治疗市场分为口服、育儿等。 2025年,家长部分占了市场的52.67%,同时广泛使用可注射的抗生素和治疗方法治疗需要迅速采取药物行动和控制下治疗的严重炭疽病例。父母管理在医院和紧急医疗环境下得到广泛青睐,特别是对系统感染或疾病晚期的病人而言。与严重炭疽感染有关的住院率上升、保健基础设施的改善以及注射式抗微生物疗法的提供,都有助于这一阶层的强大市场地位。

预计口服部分在2026年至2033年期间将出现6.5%的最快CAGR,其动力是越来越多地采用方便的门诊治疗方法,以及越来越多地使用口服抗生素治疗早期和不太严重的炭疽感染。在农村和发展中地区扩大获得保健服务的机会,同时提高保健提供者对及时开始治疗的认识,正在支持部分增长。此外,口服疗法还提供一些好处,如易于施用、治疗复杂程度降低、病人遵守规定情况改善等,从而进一步促进了整个亚太市场的需求。

按终端用户

在终端用户的基础上,亚太炭疽治疗市场分为政府组织、医院、学术研究所等。 2025年,由于医院在诊断、病人管理、急诊治疗和高级炭疽疗法的治疗方面发挥着中心作用,医院部分占了市场的46.35%。医院越来越多地采用改进的诊断工具、抗微生物治疗和感染控制规程来有效管理炭疽病例。此外,动物疫病负担日益加重,保健开支增加,整个亚太国家的医疗基础设施得到加强,这些都支持医院在市场上占主导地位。

2026年至2033年,政府组织部分预计将看到最快的CAGR(7.1%),其动力是增加对公共卫生监测、疫情预防方案和生物防御举措的投资。政府机构正在集中力量加强疾病监测系统,改善应急准备,并确保在爆发期间提供炭疽治疗资源。此外,政府机构、保健机构和传染病控制研究组织之间的合作预计将为这一部门创造重大增长机会。

亚太炭疽治疗市场区域分析

这个亚太炭疽治疗市场预计将有显著增长在政府更加重视生物防御准备、加强保健基础设施和增加对传染病监测和应急系统的投资的推动下, 诸如中国、印度和日本正在通过改进公共卫生方案和医疗对策举措,提高它们及早发现、诊断和治疗炭疽的能力。越来越需要有效的抗生素、抗毒素疗法和防疫解决办法,这正在支持区域市场的扩大。此外,对医院基础设施、研究机构和政府牵头的储存方案的投资不断增加,有助于整个区域更多地采用炭疽治疗办法。

中国炭疽治疗市场透视

这个中国炭疽治疗市场主导亚太地区,2025年收入份额最大,为35.12%.得到强有力的公共卫生基础设施、大规模政府储备方案以及先进的传染病监测能力的支持。该国注重加强生物威胁防范和改善应急系统,增加了对炭疽治疗方法的需求,包括抗生素、疫苗和抗毒素疗法。中国广泛的医疗网络,对生物技术研究的不断增长的投资,以及政府旨在控制传染病的举措,都进一步支撑了市场的增长. 政府组织在维持医疗对抗措施储备和加强疫情防备方面的作用越来越大,预计仍将是该国炭疽治疗的一个主要因素。

印度炭疽治疗市场透视

这个印度炭疽治疗市场预计是亚太区域增长最快的市场,2026至2033年的CAGR为7.8%在扩大卫生保健、增加对生物防御准备的投资以及改善医院和诊断基础设施的推动下, 政府日益重视传染病管理、农村保健发展和加强实验室能力,有助于扩大市场。印度日益壮大的生物技术部门、对动物病的认识的提高以及疾病监测系统的改进,都支持了对先进的炭疽治疗方案的需求。印度还目睹政府组织更多地参与应急准备方案、储存举措和公共卫生应对规划,使印度成为亚太区域内的一个关键增长市场。

亚太炭疽治疗市场份额

炭疽治疗行业主要由历史悠久的公司领导,其中包括:

辉瑞股份有限公司(美国)
拜耳公司(德国)
克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克
萨诺菲(法国)
默克公司(美国)
约翰逊 & Johnson (美国).
AstraZeneca plc (英国).
诺华公司(瑞士)
F. Hoffmann-La Roche有限公司(瑞士)
西普拉有限公司(印度)
太阳制药工业有限公司(印度)
Reddy博士实验室有限公司(印度)
鲁平有限公司(印度)
Mylan N.V. (Viatris Inc.) (美国).
Teva制药工业有限公司(以色列)
Eli Lily and Company (美国).
武田制药有限公司(日本)
CSL有限公司(澳大利亚)
Biogen Inc. (美国).
印度血清研究所
Bharat生物技术国际有限公司(印度)
Aurobindo Pharma有限公司(印度)
赫特罗实验室有限公司(印度)
Intas制药有限公司(印度)
Zydus生命科学有限公司(印度)
阿伦比克制药有限公司(印度)
尼古拉斯·皮拉马尔印度有限公司(印度)
沃克哈特有限公司(印度)
上海制药控股有限公司(中国)
锡诺法尔集团有限公司(中国)
Takara Bio公司(日本)
三菱Tanabe Pharma公司(日本)
大冢制药有限公司(日本)
卡肯制药有限公司(日本)
桑多兹国际股份有限公司(瑞士)
辉瑞澳大利亚有限公司(澳大利亚)
韩国医药有限公司(韩国)
韩美制药有限公司(韩国)
Celltrion公司(韩国)

亚太炭疽治疗市场的最新动态

2021年1月,美国食品药品管理局(FDA)批准了Anthim (obiltoxaximab)的标签更新,这是一种由Elusys治疗学开发的炭疽抗毒药物,将补充信息支持其使用,作为吸入炭疽治疗方法的一部分. Anthim是一种单克隆抗体疗法,旨在中和炭疽杆菌保护性抗原,并结合适当的抗菌药物使用. 对Anthim的持续监管支持加强了针对生物防御准备方案的抗毒素疗法的提供
2021年10月,生物医学高级研究开发局(BARDA)继续与生物技术公司合作,推进针对炭疽等生物威胁的医学对策. 这些举措侧重于通过研制、采购和储存疫苗、抗生素和抗毒素疗法来保持国家防范能力,以应对潜在的炭疽接触情况
2022年3月,美国政府在其"生物盾牌与战略国家库存计划"下扩大努力,以保持获得包括炭疽相关治疗和疫苗在内的关键医疗对策的机会. 该倡议通过确保提供紧急治疗和加强生物防御防范生物威胁,支持对炭疽治疗产品的持续需求
2022年9月,Emergent BioSolutions继续提供BioThrax(Anthrax Basincus Adsorbed),这是FDA批准的首个炭疽疫苗,用于美国政府的生物防御准备方案. 疫苗仍然是炭疽预防战略的关键组成部分,支持政府采购活动,加强炭疽防治在国家安全保健规划中的重要性
2023年4月,美国卫生与公众服务部(HHS)宣布继续通过BARDA投资医疗对策,以加强防范包括炭疽在内的生物威胁. 这些投资支持研究、开发、制造能力和提供快速应对可能爆发或蓄意生物事件所需的关键疗法
2023年11月,研究人员继续推进下一代炭疽治疗方法,包括以单克隆抗体为基础的治疗,并改进了旨在应对毒素介导疾病进展的抗微生物战略. 这些事态发展突出表明,人们日益重视可补充传统抗生素治疗的有针对性的疗法,特别是针对吸入性炭疽等严重形式的疗法。
2024年2月,Emergent BioSolutions宣布通过包括炭疽疫苗解决方案在内的涉及医疗对策的供应协议,继续支持美国政府的生物防御举措. 该公司的持续参与强调了可靠制造能力和长期提供炭疽预防产品对于国家备灾方案的重要性
2024年7月,美国政府继续通过"战略国家储备"开展与炭疽相关的医疗对策的采购活动,支持对炭疽疫苗,抗生素,抗毒素疗法的持续需求. 这些采购举措反映出越来越强调保持对生物紧急情况的准备,并改进应对能力
2025年3月,生物技术和公共卫生组织继续开展研究工作,重点是通过先进的生物研究平台改进炭疽诊断、治疗反应和生物防御准备。单克隆抗体、疫苗技术和快速诊断方法的持续创新支持了全球炭疽治疗生态系统的长期发展
2025年8月,全球生物防御方案继续强调综合炭疽预防战略,结合疫苗接种、抗生素疗法、抗毒素供应和应急规划。日益重视生物威胁管理,支持继续对炭疽治疗办法进行投资,并加强参与传染病防治的制药和生物技术公司的市场机会。

SKU-68920

在线获取全球首个市场情报云平台的报告访问权限

点击图片放大

交互式数据分析仪表板
用于发现高增长潜力机会的公司分析仪表板
研究分析师支持（定制与咨询）
带有交互式仪表板的竞争对手分析
最新新闻、更新与趋势分析
利用基准分析的强大功能，实现全面的竞争对手跟踪

申请演示

表格列表

TABLE 1 POPULATION AT RISK (IN MILLIONS) BY REGION, LAND USE AND OCCUPATIONAL EXPOSURE, 2020-

TABLE 2 VACCINES IN DEVELOPMENT

TABLE 3 ANTIBIOTIC CONSUMPTION ESTIMATES BY GBD SUPER-REGION AND GBD REGION, FOR THE YEAR 2018-

TABLE 4 COUNTRY DATA OF ANTIBIOTICS CONSUMPTION-

TABLE 5 RECENT M&A IN ANTHRAX MARKET-

TABLE 6 ANTIBIOTICS MEDICINES

TABLE 7 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 8 ASIA PACIFIC ANTHRAX TREATMENT MARKET, TYPE, 2020-2029 (USD MILLION)

TABLE 9 ASIA PACIFIC CUTANEOUS ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 ASIA PACIFIC CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 ASIA PACIFIC ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 ASIA PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 ASIA PACIFIC BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 ASIA PACIFIC BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 ASIA PACIFIC ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 16 ASIA PACIFIC VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 17 ASIA PACIFIC PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 ASIA PACIFIC PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 19 ASIA PACIFIC ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 ASIA PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 ASIA PACIFIC BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 ASIA PACIFIC BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 23 ASIA PACIFIC ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 ASIA PACIFIC VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 ASIA PACIFIC INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 ASIA PACIFIC INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 27 ASIA PACIFIC ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 28 ASIA PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 ASIA PACIFIC BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 30 ASIA PACIFIC BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 31 ASIA PACIFIC ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 ASIA PACIFIC VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 33 ASIA PACIFIC ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 34 ASIA PACIFIC PARENTERAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 ASIA PACIFIC ORAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 ASIA PACIFIC OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 ASIA PACIFIC ANTHRAX TREATMENT MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 ASIA PACIFIC GOVERNMENT ORGANIZATION IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 ASIA PACIFIC HOSPITALS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 ASIA PACIFIC ACADEMIC AND RESEARCH IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 ASIA PACIFIC OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 ASIA-PACIFIC ANTHRAX TREATMENT MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 ASIA-PACIFIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 ASIA-PACIFIC CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 45 ASIA-PACIFIC ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 46 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 47 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 48 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 49 ASIA-PACIFIC BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 50 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 51 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 52 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 53 ASIA-PACIFIC ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 55 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 56 ASIA-PACIFIC VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 58 ASIA-PACIFIC BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 59 ASIA-PACIFIC PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 ASIA-PACIFIC ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 61 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 62 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 63 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 64 ASIA-PACIFIC BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 65 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 66 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 67 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 68 ASIA-PACIFIC ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 70 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 71 ASIA-PACIFIC VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 73 ASIA-PACIFIC BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 74 ASIA-PACIFIC INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 75 ASIA-PACIFIC ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 78 ASIA-PACIFIC BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 79 ASIA-PACIFIC BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 82 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 83 ASIA-PACIFIC ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 84 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 85 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 86 ASIA-PACIFIC VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 87 ASIA-PACIFIC BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 88 ASIA-PACIFIC BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 89 ASIA-PACIFIC ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 90 ASIA-PACIFIC ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 91 CHINA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 92 CHINA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 93 CHINA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 94 CHINA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 95 CHINA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 96 CHINA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 97 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 99 CHINA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 101 CHINA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 103 CHINA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 CHINA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 105 CHINA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 106 CHINA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 107 CHINA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 108 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 109 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 110 CHINA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 111 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 112 CHINA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 113 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 114 CHINA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 115 CHINA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 116 CHINA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 117 CHINA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 118 CHINA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 119 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 121 CHINA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 123 CHINA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 CHINA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 125 CHINA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 126 CHINA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 127 JAPAN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 128 JAPAN CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 129 JAPAN ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 130 JAPAN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 131 JAPAN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 132 JAPAN BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 133 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 134 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 135 JAPAN ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 136 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 137 JAPAN VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 138 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 139 JAPAN PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 140 JAPAN ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 141 JAPAN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 142 JAPAN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 143 JAPAN BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 146 JAPAN ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 147 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 148 JAPAN VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 149 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 150 JAPAN INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 151 JAPAN ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 152 JAPAN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 153 JAPAN BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 154 JAPAN BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 155 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 156 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 157 JAPAN ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 158 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 159 JAPAN VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 160 JAPAN BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 161 JAPAN ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 162 JAPAN ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 163 SOUTH KOREA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 SOUTH KOREA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 165 SOUTH KOREA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 SOUTH KOREA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 167 SOUTH KOREA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 168 SOUTH KOREA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 169 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 170 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 171 SOUTH KOREA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 172 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 173 SOUTH KOREA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 174 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 175 SOUTH KOREA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 176 SOUTH KOREA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 177 SOUTH KOREA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 178 SOUTH KOREA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 179 SOUTH KOREA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 180 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 181 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 182 SOUTH KOREA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 183 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 184 SOUTH KOREA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 185 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 186 SOUTH KOREA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 187 SOUTH KOREA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 188 SOUTH KOREA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 SOUTH KOREA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 190 SOUTH KOREA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 191 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 192 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 193 SOUTH KOREA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 194 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 195 SOUTH KOREA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 196 SOUTH KOREA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 197 SOUTH KOREA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 198 SOUTH KOREA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 199 INDIA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 200 INDIA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 201 INDIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 202 INDIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 203 INDIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 204 INDIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 205 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 206 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 207 INDIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 208 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 209 INDIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 211 INDIA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 212 INDIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 213 INDIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 214 INDIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 215 INDIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 216 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 217 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 218 INDIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 219 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 220 INDIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 221 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 222 INDIA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 223 INDIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 224 INDIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 225 INDIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 226 INDIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 227 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 228 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 229 INDIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 230 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 231 INDIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 INDIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 233 INDIA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 234 INDIA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 235 AUSTRALIA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 236 AUSTRALIA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 237 AUSTRALIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 238 AUSTRALIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 239 AUSTRALIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 240 AUSTRALIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 241 AUSTRALIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 242 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 243 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 244 AUSTRALIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 245 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 246 AUSTRALIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 247 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 248 AUSTRALIA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 249 AUSTRALIA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 250 AUSTRALIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 251 AUSTRALIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 AUSTRALIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 253 AUSTRALIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 254 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 255 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 256 AUSTRALIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 257 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 258 AUSTRALIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 259 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 260 AUSTRALIA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 261 AUSTRALIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 262 AUSTRALIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 263 AUSTRALIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 264 AUSTRALIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 265 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 266 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 267 AUSTRALIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 268 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 269 AUSTRALIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 270 AUSTRALIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 271 AUSTRALIA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 272 AUSTRALIA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 273 SINGAPORE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 274 SINGAPORE CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 275 SINGAPORE ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 276 SINGAPORE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 277 SINGAPORE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 278 SINGAPORE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 279 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 280 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 281 SINGAPORE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 282 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 283 SINGAPORE VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 284 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 285 SINGAPORE PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 286 SINGAPORE ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 287 SINGAPORE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 288 SINGAPORE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 289 SINGAPORE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 290 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 291 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 292 SINGAPORE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 293 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 294 SINGAPORE VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 295 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 296 SINGAPORE INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 297 SINGAPORE ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 298 SINGAPORE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 299 SINGAPORE BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 300 SINGAPORE BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 301 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 302 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 303 SINGAPORE ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 304 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 305 SINGAPORE VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 306 SINGAPORE BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 307 SINGAPORE ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 308 SINGAPORE ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 309 THAILAND ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 310 THAILAND CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 311 THAILAND ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 312 THAILAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 313 THAILAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 314 THAILAND BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 315 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 316 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 317 THAILAND ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 318 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 319 THAILAND VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 320 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 321 THAILAND PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 322 THAILAND ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 323 THAILAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 324 THAILAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 325 THAILAND BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 326 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 327 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 328 THAILAND ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 329 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 330 THAILAND VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 331 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 332 THAILAND INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 333 THAILAND ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 334 THAILAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 335 THAILAND BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 336 THAILAND BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 337 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 338 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 339 THAILAND ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 340 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 341 THAILAND VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 342 THAILAND BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 343 THAILAND ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 344 THAILAND ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 345 MALAYSIA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 346 MALAYSIA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 347 MALAYSIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 348 MALAYSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 349 MALAYSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 350 MALAYSIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 351 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 352 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 353 MALAYSIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 354 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 355 MALAYSIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 356 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 357 MALAYSIA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 358 MALAYSIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 359 MALAYSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 360 MALAYSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 361 MALAYSIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 362 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 363 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 364 MALAYSIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 365 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 366 MALAYSIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 367 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 368 MALAYSIA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 369 MALAYSIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 370 MALAYSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 371 MALAYSIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 372 MALAYSIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 373 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 374 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 375 MALAYSIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 376 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 377 MALAYSIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 378 MALAYSIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 379 MALAYSIA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 380 MALAYSIA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 381 INDONESIA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 382 INDONESIA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 383 INDONESIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 384 INDONESIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 385 INDONESIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 386 INDONESIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 387 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 388 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 389 INDONESIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 390 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 391 INDONESIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 392 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 393 INDONESIA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 394 INDONESIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 395 INDONESIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 396 INDONESIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 397 INDONESIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 398 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 399 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 400 INDONESIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 401 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 402 INDONESIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 403 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 404 INDONESIA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 405 INDONESIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 406 INDONESIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 407 INDONESIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 408 INDONESIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 409 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 410 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 411 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 412 INDONESIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 413 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 414 INDONESIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 415 INDONESIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 416 INDONESIA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 417 INDONESIA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 418 PHILIPPINES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 419 PHILIPPINES CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 420 PHILIPPINES ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 421 PHILIPPINES BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 422 PHILIPPINES BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 423 PHILIPPINES BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 424 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 425 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 426 PHILIPPINES ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 427 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 428 PHILIPPINES VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 429 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 430 PHILIPPINES PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 431 PHILIPPINES ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 432 PHILIPPINES BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 433 PHILIPPINES BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 434 PHILIPPINES BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 435 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 436 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 437 PHILIPPINES ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 438 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 439 PHILIPPINES VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 440 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 441 PHILIPPINES INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 442 PHILIPPINES ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 443 PHILIPPINES BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 444 PHILIPPINES BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 445 PHILIPPINES BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 446 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 447 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 448 PHILIPPINES ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 449 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 450 PHILIPPINES VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 451 PHILIPPINES BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 452 PHILIPPINES ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 453 PHILIPPINES ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 454 REST OF ASIA-PACIFIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 ASIA PACIFIC ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC ANTHRAX TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC ANTHRAX TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC ANTHRAX TREATMENT MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC ANTHRAX TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC ANTHRAX TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA PACIFIC ANTHRAX TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 ASIA PACIFIC ANTHRAX TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 ASIA PACIFIC ANTHRAX TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 11 MIDDLE EAST & AFRICA IS ANTICIPATED TO DOMINATE THE ANTHRAX TREATMENT MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASING INCIDENCE AND PREVALENCE OF ANTHRAX INFECTIONS ARE EXPECTED TO DRIVE THE ASIA PACIFIC ANTHRAX TREATMENT MARKET IN THE FORECAST PERIOD

FIGURE 13 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC ANTHRAX TREATMENT MARKET IN 2022 & 2029

FIGURE 14 ASIA PACIFIC DISTRIBUTION OF OUTBREAKS BY COUNTRY AND GEOGRAPHIC LOCATIONS OF ANTHRAX EVENTS-

FIGURE 15 PATHOPHYSIOLOGY OF ANTHRAX-

FIGURE 16 FLOW CHART FOR SUSPECTED ANTHRAX EXPOSURE-

FIGURE 17 GC BIOPHARMA ANTHRAX CANDIDATE GC1109 IS IN PHASE 2 (NCT01624532).

FIGURE 18 BA-ISTAB IS A FUSION OF A B. ANTHRACIS SPECIFIC CWT WITH A POTENT MONOCLONAL ANTIBODY THAT NEUTRALIZE ANTHRAX TOXIN (PA).

FIGURE 19 TWO ROUTES BY WHICH VACCINATION CAN REDUCE INCIDENCE OF AMR-

FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA PACIFIC ANTHRAX TREATMENT MARKET

FIGURE 21 ASIA PACIFIC ANTHRAX TREATMENT MARKET : TYPE, 2021

FIGURE 22 ASIA PACIFIC ANTHRAX TREATMENT MARKET : TYPE, 2022-2029 (USD MILLION)

FIGURE 23 ASIA PACIFIC ANTHRAX TREATMENT MARKET : TYPE, CAGR (2022-2029)

FIGURE 24 ASIA PACIFIC ANTHRAX TREATMENT MARKET : TYPE, LIFELINE CURVE

FIGURE 25 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2021

FIGURE 26 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)

FIGURE 27 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)

FIGURE 28 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY END USER, 2021

FIGURE 30 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY END USER, 2022-2029 (USD MILLION)

FIGURE 31 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY END USER, CAGR (2022-2029)

FIGURE 32 ASIA PACIFIC ANTHRAX TREATMENT MARKET : BY END USER, LIFELINE CURVE

FIGURE 33 ASIA-PACIFIC ANTHRAX TREATMENT MARKET: SNAPSHOT (2021)

FIGURE 34 ASIA-PACIFIC ANTHRAX TREATMENT MARKET: BY COUNTRY (2021)

FIGURE 35 ASIA-PACIFIC ANTHRAX TREATMENT MARKET: BY COUNTRY (2022 & 2029)

FIGURE 36 ASIA-PACIFIC ANTHRAX TREATMENT MARKET: BY COUNTRY (2021 & 2029)

FIGURE 37 ASIA-PACIFIC ANTHRAX TREATMENT MARKET: BY TYPE (2022-2029)

FIGURE 38 ASIA PACIFIC ANTHRAX TREATMENT MARKET: COMPANY SHARE 2021(%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。